BriaCell Therapeutics Stock (NASDAQ: BCTX) stock price, news, charts, stock research, profile.
Open | $2.640 |
Close | $2.860 |
Volume / Avg. | 87.185K / 107.729K |
Day Range | 2.600 - 2.940 |
52 Wk Range | 2.190 - 7.750 |
Market Cap | $44.429M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 5.84% |
Days to Cover | 7.84 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of BriaCell Therapeutics (NASDAQ: BCTX) through any online brokerage.
There are no as such competitors for BriaCell Therapeutics.
The latest price target for BriaCell Therapeutics (NASDAQ: BCTX) was reported by HC Wainwright & Co. on Thursday, December 28, 2023. The analyst firm set a price target for 18.00 expecting BCTX to rise to within 12 months (a possible 547.48% upside). 3 analyst firms have reported ratings in the last year.
The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $2.78 last updated Today at March 28, 2024 at 8:19 AM EDT.
There are no upcoming dividends for BriaCell Therapeutics.
BriaCell Therapeutics’s Q3 earnings are confirmed for Wednesday, June 12, 2024.
There is no upcoming split for BriaCell Therapeutics.
BriaCell Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.